# Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

> **NCT00737867** · PHASE3 · COMPLETED · sponsor: **The Norwegian Lung Cancer Study Group** · enrollment: 444 (estimated)

## Conditions studied

- Advanced Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Vinorelbine
- **DRUG:** Gemcitabine
- **DRUG:** Vinorelbine
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00737867
- **Lead sponsor:** The Norwegian Lung Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 444 (ESTIMATED)
- **Last updated:** 2011-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00737867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00737867, "Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00737867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*